CN Patent

CN101247786A — 醋酸泼尼松龙的口服悬浮液

Assigned to Taro Pharmaceuticals North America Inc · Expires 2008-08-20 · 18y expired

What this patent protects

本发明涉及新型口服悬浮制剂，其包含醋酸泼尼松龙、药学上可接受的载体和增稠剂。本发明进一步提供了一种用该新型制剂来治疗需要泼尼松龙的患者的方法。

USPTO Abstract

本发明涉及新型口服悬浮制剂，其包含醋酸泼尼松龙、药学上可接受的载体和增稠剂。本发明进一步提供了一种用该新型制剂来治疗需要泼尼松龙的患者的方法。

Drugs covered by this patent

prednisolone-acetate (PREDNISOLONE ACETATE)

Patent Metadata

Patent number: CN101247786A
Jurisdiction: CN
Classification: —
Expires: 2008-08-20
Drug substance claim: No
Drug product claim: No
Assignee: Taro Pharmaceuticals North America Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.